Newly diagnosed
Clarify the type, stage, biomarkers and decisions that may need to happen first.
Sunridge Medical · Scottsdale, Arizona
Breast Cancer Treatment Options & Integrative Oncology
If you have breast cancer, call us before you decide what comes next. We can help.
From a new diagnosis to recurrent or metastatic disease, we review subtype, biomarkers, stage and treatment history to help build an individualized plan.
New diagnoses, recurrence, advanced disease and second-opinion questions are welcome.
Talk With Our Breast Cancer Patient Care Team
There is no charge to speak with our Patient Care Team about your breast cancer diagnosis, ask practical questions and learn whether a physician consultation may be an appropriate next step.
Prefer to speak now?Call 1-800-923-7878This introductory call is free. It is not a medical consultation and does not establish a physician-patient relationship.
Breast Cancer Treatment Information · Scottsdale, Arizona
Breast Cancer Treatment Options: Personalized Integrative Oncology by Subtype and Stage
Sunridge Medical reviews the complete breast cancer story—stage, ER/PR/HER2 status, pathology, prior response, current treatment and the person living through the diagnosis—to build a physician-directed plan around the next decision.
Looking for more treatment options? We evaluate newly diagnosed, Stage 3, recurrent and metastatic breast cancer; support patients before, during or after standard oncology treatment; and can coordinate with an oncologist at home.
Complex cases welcomeOutside-oncologist coordinationTravel patients supported20+ years serving patients
Cancer Consultation
Speak With Our Cancer Patient Care Team
Tell us where you are in your cancer journey. Our Patient Care Team can answer questions and help determine the next step.
* Required fields
Prefer to speak with someone now?
1-800-923-7878 ✓ Stage 4 & advanced cancer patients welcome
✓ Out-of-state & international patients welcome
✓ Questions before scheduling are welcome
Start with the decision in front of you
Breast cancer treatment information should help you know what to do next .
Some people arrive with a new pathology report. Others have already completed surgery, radiation, chemotherapy, endocrine therapy, immunotherapy or targeted therapy and want to understand what else may be considered. The most useful review begins with where you are now.
During treatment
Review the complete schedule, symptoms, nutrition, recovery needs and interaction safety.
After treatment or at recurrence
Reassess the timeline, new pathology or imaging, current health and the goals of another treatment plan.
Seeking a second opinion
Bring the reports, current recommendations and the questions you want an additional physician review to address.
Breast cancer treatment options at a glance
Different tools play different roles in breast cancer care.
A treatment plan may use local treatment, systemic treatment, supportive care and physician-directed integrative strategies. Which options are appropriate—and in what order—depends on stage, tumor biology, previous treatment, health status and individual goals.
Surgery
Breast -conserving surgery, mastectomy and lymph-node procedures may be used for local disease control and staging when appropriate.
Radiation therapy
Radiation may reduce the risk of local recurrence or treat specific areas of disease. Timing and field depend on the individual case.
Chemotherapy
Cytotoxic medicines may be used before surgery, after surgery or for advanced disease based on risk, subtype and response.
Endocrine therapy
Hormone-blocking treatment is central to many ER-positive and PR -positive breast cancers and often requires long-term planning.
Targeted therapy
HER2 -directed and other targeted medicines are selected when testing identifies a relevant tumor feature or pathway.
Immunotherapy
Some patients—particularly within defined triple-negative settings—may be evaluated for immune-based treatment using current clinical criteria .
Precision and supportive care
Genomic findings, bone-directed care, symptom management, rehabilitation and nutrition can affect both decisions and day-to-day function.
Integrative oncology
Sunridge evaluates physician-directed therapies, metabolic and immune context, nutrition and recovery needs within the complete oncology plan .
Breast cancer medicine is not one medication.
Patients may encounter chemotherapy drugs, endocrine medicines, HER2-targeted agents, immunotherapy, antibody-drug conjugates, bone-modifying medicines and symptom-control prescriptions. Sunridge reviews the exact medication list and treatment calendar before recommending supplements, infusions or other integrative therapies.
How treatment changes by stage
Stage describes the extent of disease—but it does not tell the whole story.
Non-invasive disease
Decisions can include surgery, radiation and endocrine risk reduction, guided by the pathology and the individual’s priorities .
Early-stage breast cancer
Local treatment and systemic-risk reduction are planned around tumor size, lymph nodes, subtype, genomic risk and patient factors.
Locally advanced breast cancer
Stage 3 care often requires several coordinated treatments. Response to preoperative therapy, surgery planning, radiation and subtype-specific systemic treatment all matter.
Metastatic or recurrent breast cancer
Care becomes an ongoing process focused on disease control, treatment sequencing, function, symptoms and quality of life.
Explore metastatic breast cancer care →Start with the biology
One diagnosis. Several very different treatment pathways.
Subtype
HER2 -positive
HER2 overexpression or amplification creates a treatment target and a distinct care pathway.
HER2-positive guide →Subtype
Hormone receptor-positive
ER-positive and/or PR-positive tumors are influenced by hormone signaling and may require long-term endocrine planning.
Hormone-positive guide →Subtype
Triple -negative
TNBC lacks ER, PR and HER2 targets, making stage, genetics, PD-L1 and treatment response especially important.
Triple-negative guide →Changing biology
HER2-low and recurrent disease
Testing definitions and tumor biology can change over time, creating different treatment questions after progression or recurrence.
Explore HER2-low care →Testing that can change the plan
Pathology, biomarkers and the patient’s present health belong in the same conversation.
- Confirm ER, PR and HER2 results and review equivocal or changing findings.
- Review tumor grade, lymph nodes, margins, imaging and the complete treatment timeline.
- Consider germline testing such as BRCA1, BRCA2 and PALB2 when clinically appropriate.
- Use tumor genomic or liquid-biopsy information when it can identify an actionable pathway.
- Review blood counts, chemistry, nutritional status, inflammatory patterns and selected immune-function measurements in context.
- Discuss repeat biopsy in recurrent or metastatic disease when feasible because tumor biology can change.
Additional care without losing continuity
Sunridge can work alongside the oncologist who already knows your case .
Many patients come to Scottsdale while continuing care with a medical oncologist, surgical oncologist or radiation oncologist near home. With the patient’s permission, records and treatment schedules can be reviewed so that recommendations are made with the existing plan in view.
What coordinated care should include
- A complete medication, supplement and infusion list
- Exact chemotherapy, radiation, immunotherapy or targeted -therapy timing
- Review for potential interactions and overlapping side effects
- Clear documentation of the goals of Sunridge care
- Reassessment when the oncology plan or disease status changes
When a second opinion may help
- Before a major treatment decision
- When pathology or biomarker results are uncertain
- At recurrence, progression or a new Stage 3/Stage 4 diagnosis
- When treatment has become difficult to tolerate
- When you want to understand additional integrative options
The Sunridge approach
Ambitious care still begins with disciplined case review.
Sunridge is a physician-directed outpatient medical center in Scottsdale. The team evaluates complex cancer cases, including patients who have received multiple prior treatments, while keeping safety, treatment timing and measurable goals central to the program.
Infusion support
Physician-directed support
Supportive care may include selected in-office therapies when medically appropriate, coordinated with the oncology plan, current medications and laboratory findings.
Botanical research
Interaction-aware planning
Nutritional and botanical approaches are evaluated for evidence, safety, dose, treatment goals and potential interactions with cancer therapy.
Emerging modality
Molecular hydrogen
Hydrogen inhalation is an emerging integrative modality studied in oxidative-stress, inflammatory and treatment-support contexts.
Immune context
Deeper immune assessment
Selected patients may discuss lymphocyte subsets, natural killer cell number or activity and related immune markers as part of a broader assessment.
Traveling to Scottsdale for treatment
People travel to Sunridge from across the United States and internationally. The Patient Care Team can explain which records to send first, how treatment timing may fit with oncology care at home, which services require an in-person visit and how to plan time in Scottsdale.
Clinic: 14200 N Northsight Blvd, Suite 160, Scottsdale, Arizona 85260 · 1-800-923 -7878
Patient experiences
Hear from people who traveled their own breast cancer path.
These stories describe individual experiences and are not promises of results. Images are loaded only as they enter the screen, and videos open separately to keep this page fast.
Breast cancer
Christiana · New York
A Sunridge patient shares her personal care experience.
Watch the story ↗Breast cancer
Marika · Indiana
A Sunridge patient shares her personal care experience .
Watch the story ↗Stage IV breast cancer
Adena · Phoenix
A Sunridge patient shares her personal care experience.
Watch the story ↗
